Abstract
Neuropsychiatric manifestations may be seen following exposure to mercury. The signs and symptoms vary with the form and type of compound involved. Although elemental mercury is not absorbed, poisoning may occur from mercury vapors, organic compounds, and soluble and insoluble inorganic compounds. Acute mercury poisoning, usually the result of ingestion of soluble salts such as mercury chloride, either by accident or with suicidal intent, is an acute medical crisis. Symptoms occur quickly and are caused by severe local inflammation of the gastrointestinal tract and renal toxicity. Anuria and uremia are the usual causes of death.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adamson JS, Flanigan WJ, Ackerman GL: Treatment of bromide intoxication with ethacrynic acid and mannitol diuresis. Ann Intern Med 65: 749 – 752, 1966.
Agate JN, Buchnell M: Mercury poisoning from fingerprint photography; An occupational hazard of policemen. Lancet 2: 451 – 454, 1949.
Baloh R, Sturm R, Green B, Glesen G: Neuropsychological effect of chronic asymptomatic increased lead absorption. Arch Neurol 32: 326 – 330, 1975.
Benning D: Outbreak of mercury poisoning in Ohio. Ind Med Surg 27: 354 – 363, 1958.
Biskind MS, Mobbs RE: Psychiatric manifestations from insecticide exposure. JAMA 220: 1248 – 1250, 1972.
Blench TH, Brindle H: Fingerprint detection and mercury poisoning. Lancet 1: 378 – 380, 1951.
Blume RS, MacLowry JD, Wolff SM: Limitations of chloride determination in the diagnosis of bromism. N Eng J Med 279: 593 – 595, 1968.
Bowers MB, Goodman E, Sim VM: Some behavioral changes in man following anticholinesterase administration. J Nery Ment Dis 138: 383 – 389, 1964.
Browne DC, McHardy G, Edwards EW: Amebiasis: A clinical evaluation. New Orleans Med Surg J 102: 475 – 481, 1950.
Buge A, Pancurel G, Poisson M, et al: Twenty cases of acute encephalopathy with myoclonia during treatment with oral bismuth salts. Ann Med Interne (Paris) 125: 877 – 888, 1974.
Burns R, Thomas DW, Barron VJ: Reversal encephalopathy possibly associated with bismuth subgallate ingestion. Br Med J 1: 220 – 223, 1974.
Carney MWP: Five cases of bromism. Lancet 2: 523 - 524, 1971.
Carney MWP: Bromism—A clinical chameleon. Nursing Times 69:859-860, 1973. Cassells DK, Dodds EC: Tetra-ethyl lead poisoning. Br Med J 2: 681 – 685, 1946.
Cheatham JS, Chobot EF: The clinical diagnosis and treatment of lead encephalopathy. South Med J 61: 529 – 531, 1968.
Cole M, Scheulein M, Kerwin DM: Arsenical encephalopathy due to the use of milibis. Arch Intern Med 117: 706 – 711, 1966.
Conyers RJ, Goldsmith LE: A case of organophosphorus-induced psychosis. Med J Aust 58: 27 – 29, 1971.
Crutcher IC: Clincial manifestations and therapy of acute lead intoxication due to the ingestion of illicitly distilled alcohol. Ann Intern Med 59: 707 – 715, 1963.
Dille JR, Smith TW: Central nervous system effects of chronic exposure to organophosphate insecticides. Aerosp Med 35: 475 – 478, 1964.
Durham WF, Wolfe HR, Quinby GE: Organophosphorus insecticides and mental alertness. Arch Environ Health 10: 55 – 66, 1965.
Ewing JA, Grant WJ: The bromide hazard. South Med J 58: 148 – 152, 1965.
Felton JS, Kahn E, Salick B, et al. Heavy metal poisoning: Mercury and lead. Ann Intern Med 76: 779 – 792, 1972.
Fischbein A, Rice C, Sarkozi L, Kon SH, Petrocci M, Selikoff IJ: Exposure to lead in firing ranges. JAMA 241: 1141 – 1144, 1979.
Frank G: Neurologische and psychiarische folgesymptomie bei akuter arsen-wasserstoff-vergiftung. J Neurol 70: 213 – 259, 1976.
Freeman JA: Mercurial disease among hatters. Trans NJ State Med Soc 61: 64, 1860.
Freeman JW, Couch JR: Prolonged encephalopathy with arsenic poisoning. Neurology 28: 853 - 855, 1978.
Frost J, Paulsen E: Poisoning due to parathion and other organophosphorous insecticides in Denmark. Dan Med Bull 11: 169 - 173, 1964.
Gastaut JL, Tassinari CA, Terzano G, et al: Etude polygraphique de l'ence thalopathie myoclonique bismuthique. Revue EEG at Neurophysiologie Clinique 3: 295 - 302, 1975.
Gershon S, Shaw FH: Psychiatric sequelae of chronic exposure to organophosphorus insecticides. Lancet 1: 1371 - 1374, 1961.
Gowdy JM, Demers FX: Whole blood mercury levels in mental hospital patients. Am J Psychiatry 135: 115 - 117, 1978.
Gowdy JM, Demers FX, Yates RL: Blood mercury levels in a hospitalized urban population. J Sci Total Environ (in press).
Grob D, Harvey A: The effects and treatment of nerve gas poisoning. Am J Med 14: 52 - 63, 1953.
Hanes FM, Yates A: An analysis of four hundred instances of chronic bromide intoxication. South Med J 31: 667 - 671, 1938.
Harvey SC: Heavy metals, in Goodman LS, Gilman W (eds): The Pharmacological Basis of Therapeutics, ed 4. New York, MacMillan Co., 1970, p 967.
Harvey SC: Heavy metals, in Goodman LS, Gilman W (eds): The Pharmacological Basis of Therapeutics, ed 5. New York, MacMillan Co., 1975, pp 924 - 928.
Hunter D: Industrial poisoning: V. Mercury. Brit Encyclopedia of Medical Practice 12:139-140, London, Butterworth, 1939.
Janowsky DS, El-Yousef MK, Davis JM, et al: A cholinergic–adrenergic hypothesis of mania and depression. Lancet 2: 632 - 635, 1972.
Janowsky DS, El-Yousef MK, Davis JM, et al. Antagonistic effects of physostigmine and methylphenidate in man. Am J Psychiatry 130: 1370 - 1376, 1973.
Jenkins RB: Inorganic arsenic and the nervous system. Brain 89: 479 - 498, 1966.
Krüger G, Thomas DJ: Disturbed oxidative metabolism in organic brain syndrome caused by bismuth in skin creams. Lancet 4: 485 - 487, 1976.
Law WR, Nelson ER: Gasoline sniffing by an adult: Report of a case with the unusual complication of lead encephalopathy. JAMA 204: 1002 - 1004, 1968.
Levin HS, Rodnitzky RL, Mick DL: Anxiety associated with exposure to organophosphate compounds. Arch Gen Psychiatry 33: 225 - 228, 1976.
Levin M: Bromide psychosis: Four varieties. Am J Psychiatry 104: 798 - 800, 1948.
McDanal CE, Owens D, Bolman WM: Bromide abuse: A continuing problem. Am J Psychiatry 131: 913 - 915, 1974.
Maghazaji HI: Psychiatric aspects of methyl mercury poisoning. J Neurol Neurosurg Psychiatry 37: 954 - 958, 1974.
Metcalf DR, Holmes JH: EEG, psychological and neurological alterations in humans with organophosphate exposure. Ann NY Acad Sci 160: 357 - 365, 1969.
Miller G, Chamberlain R, McCormack WM: An outbreak of neuromyasthenia in a Kentucky factory—the possible role of a brief exposure to organic mercury. Am JEpidemiol 86: 756 - 764, 1967.
Monseu G, Struelens M, Roland M: Bismuth encephalopathy. Acta Neurol Belg 76: 301 - 308, 1976.
Morgan JM, Oh Sj, Linn GE: Lead neuropathy in alcoholics. Ala J Med Sci 8: 67 - 74, 1971.
Morris CE, Heyman A, Pozefsky T: Lead encephalopathy caused by ingestion of illicitly distilled whiskey. Neurology 14: 493 - 499, 1964.
Muller DJ: Bromide intoxication continues to occur. Tex Med 64: 72 - 73, 1968.
Namba T, Nolte CT, Jackrel J, et al: Poisoning due to organophosphate insecticides: Acute and chronic manifestations. Am J Med 50: 475 - 492, 1971.
Neal PA, Jones RR: Chronic mercurialism in the hatters' fur-cutting industry. JAMA 110: 337 - 342, 1938.
Needleman HL, Scanlon J: Getting the lead out. N Engl J Med 288: 466 - 467, 1973.
Okinaka S, Yoshikawa M, Mozai T, et al: Encephalomyelopathy due to an organic mercury compound. Neurology 14: 69 - 76, 1964.
Palatucci DM: Paradoxical halide levels in bromide intoxication. Neurology 28: 1189 - 1191, 1978.
Pearlstein MA, Attala R: Neurologic sequelae of plumbism in children. Clin Pediatr 5: 292 - 294, 1966.
Perkins HA: Bromide intoxication. Arch Intern Med 85: 783 - 794, 1950.
Pleasure JR, Blackburn MG: Neonatal bromide intoxication: Prenatal ingestion of a large quantity of bromides with transplacental accumulation in the fetus. Pediatrics 55: 503 - 506, 1975.
Poskanzer DC: Heavy metals, in Thorn GW, Adams RD, Braunwald E, et al (eds): Harrison's Principles of Internal Medicine, ed 8. New York, McGraw–Hill, 1977, p 706.
Raskind MA, Kitchell M, Alvarez C: Bromide intoxication in the elderly. J Am Geriatr Soc 26: 222 - 224, 1978.
RedHead IH: Poisoning on the farm. Lancet 1: 686 - 687, 1968.
Reich GA, Davis JH, Davis JE: Pesticide poisoning in South Florida. Arch Environ Health (Chicago) 17: 768 - 771, 1968.
Reick RR: Chronic bromide intoxication. Minn Med 54: 995 - 996, 1971.
Repko JD, Corum CR: Critical review and evaluation of the neurologic behavioral sequelae of inorganic lead absorption. Crit Rev Toxicol 6: 135 - 187, 1979.
Robertson JF: Mental illness or metal illness? Bismuth subgallate. Med J Aust 1: 887 - 888, 1974a.
Robertson JF: Comments: Bismuth subgallate poisoning. Med J Aust 2: 648 - 649, 1974b.
Rodnitzky RL, Levin MS, Mick DL: Occupational exposure to organophosphate pesticides. Arch Environ Health 30: 98 - 103, 1975.
Rollins RL, Cefalu SJ: Bromide ingestion in alcoholics. NC Med J 29: 342 - 343, 1968.
Ross WD, Gechman AS, Sholiton MC, et al: Need for alertness to neuropsychiatric manifestations of inorganic mercury poisoning. Compr Psychiatry 18: 595 – 599, 1977.
Rowntree DW, Nevin S, Wilson A: The effects of iisopropylfluorophosphonate in schizo-phrenia and manic-depressive psychosis. J Neurol Neurosurg Psychiatry 13: 472 – 478, 1950.
Sanders LW: Tetraethyl lead intoxication. Arch Environ Health 8: 270 – 277, 1964.
Schenk VW, Stolk PJ: Psychosis following arsenic (possible thallium) poisoning. Psychiatr Neurol Neurochir 70: 31 – 37, 1967.
Segal I, Saffer D, Segal F: Diverse neurologic manifestations of lead encephalopathy. S Afr Med J 48: 1721 – 1722, 1974.
Serpe SJ: Bromide intoxication. New York State J Med 72: 2086 – 2088, 1972.
Sharpless SK: Hypnotics and sedatives. II. Miscellaneous agents, in Goodman LS, Gilman A (eds): The Pharmacological Basis of Therapeutics, ed 4. New York, Macmillan Co., 1970, pp 121 – 123.
Snyder RD: The involuntary movements of chronic mercury poisoning. Arch Neurol 26: 379 – 381, 1972.
Stoller A, Krupinski J, Christophers AJ, et al: Organophosphorus insecticides and major mental illness. Lancet 1: 1387 – 1388, 1965.
Study Group of Minamata Disease: Minamata Disease, Kumamoto University, Kumamoto, Japan, 1968.
Supino-Viterbo V, Sicard C, Riszegliato M, et al: Toxic encephalopathy due to ingestion of bismuth salts: Clinical and EEG studies of 45 patients. J Neurol Neurosurg Psychiatry 40: 748 – 752, 1977.
Tabershaw JR, Cooper WC: Sequelae of acute organic phosphate poisoning. J Occup Med 8: 5 – 8, 1966.
Taylor CC: Chemical toxicity in mental disorder. Am J Psychiatry 131: 609, 1974.
Toivonen T, Ohela K, Kaipain WJ: Parathion poisoning. Increasing frequently in Finland. Lancet 2: 175, 1959.
Trump DL, Hochberg MC: Bromide intoxication. Johns Hopkins Med J 138: 119 – 123, 1976.
Victor M, Adams RD, Collins GH: The Wernicke—Korsakoff Syndrome. Philadelphia, Davis, 1971.
Wilkinson P, Horvath TB, Santamaria JN, et al: Bromism in association with alcoholism: A report of 5 cases. Med J Aust 1: 1352 – 1355, 1969.
Wuth O: Rational bromide treatment. JAMA 88: 2013 – 2017, 1927.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1981 Plenum Publishing Corporation
About this chapter
Cite this chapter
Jefferson, J.W., Marshall, J.R. (1981). Toxin Disorders. In: Neuropsychiatric Features of Medical Disorders. Critical Issues in Psychiatry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3920-5_13
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3920-5_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3922-9
Online ISBN: 978-1-4684-3920-5
eBook Packages: Springer Book Archive